Cargando…
Blockade of IL-33 release and suppression of type 2 innate lymphoid cell responses by helminth secreted products in airway allergy
Helminth parasites such as the nematode Heligmosomoides polygyrus strongly inhibit T helper type 2 (Th2) allergy, as well as colitis and autoimmunity. Here, we show that the soluble excretory/secretory products of H. polygyrus (HES) potently suppress inflammation induced by allergens from the common...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016792/ https://www.ncbi.nlm.nih.gov/pubmed/24496315 http://dx.doi.org/10.1038/mi.2013.123 |
_version_ | 1782315564338774016 |
---|---|
author | McSorley, H J Blair, N F Smith, K A McKenzie, A N J Maizels, R M |
author_facet | McSorley, H J Blair, N F Smith, K A McKenzie, A N J Maizels, R M |
author_sort | McSorley, H J |
collection | PubMed |
description | Helminth parasites such as the nematode Heligmosomoides polygyrus strongly inhibit T helper type 2 (Th2) allergy, as well as colitis and autoimmunity. Here, we show that the soluble excretory/secretory products of H. polygyrus (HES) potently suppress inflammation induced by allergens from the common fungus Alternaria alternata. Alternaria extract, when administered to mice intranasally with ovalbumin (OVA) protein, induces a rapid (1–48 h) innate response while also priming an OVA-specific Th2 response that can be evoked 14 days later by intranasal administration of OVA alone. In this model, HES coadministration with Alternaria/OVA suppressed early IL-33 release, innate lymphoid cell (ILC) production of IL-4, IL-5, and IL-13, and localized eosinophilia. Upon OVA challenge, type 2 ILC (ILC2)/Th2 cytokine production and eosinophilia were diminished in HES-treated mice. HES administration 6 h before Alternaria blocked the allergic response, and its suppressive activity was abolished by heat treatment. Administration of recombinant IL-33 at sensitization with Alternaria/OVA/HES abrogated HES suppression of OVA-specific responses at challenge, indicating that suppression of early Alternaria-induced IL-33 release could be central to the anti-allergic effects of HES. Thus, this helminth parasite targets IL-33 production as part of its armory of suppressive effects, forestalling the development of the type 2 immune response to infection and allergic sensitization. |
format | Online Article Text |
id | pubmed-4016792 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-40167922014-09-01 Blockade of IL-33 release and suppression of type 2 innate lymphoid cell responses by helminth secreted products in airway allergy McSorley, H J Blair, N F Smith, K A McKenzie, A N J Maizels, R M Mucosal Immunol Article Helminth parasites such as the nematode Heligmosomoides polygyrus strongly inhibit T helper type 2 (Th2) allergy, as well as colitis and autoimmunity. Here, we show that the soluble excretory/secretory products of H. polygyrus (HES) potently suppress inflammation induced by allergens from the common fungus Alternaria alternata. Alternaria extract, when administered to mice intranasally with ovalbumin (OVA) protein, induces a rapid (1–48 h) innate response while also priming an OVA-specific Th2 response that can be evoked 14 days later by intranasal administration of OVA alone. In this model, HES coadministration with Alternaria/OVA suppressed early IL-33 release, innate lymphoid cell (ILC) production of IL-4, IL-5, and IL-13, and localized eosinophilia. Upon OVA challenge, type 2 ILC (ILC2)/Th2 cytokine production and eosinophilia were diminished in HES-treated mice. HES administration 6 h before Alternaria blocked the allergic response, and its suppressive activity was abolished by heat treatment. Administration of recombinant IL-33 at sensitization with Alternaria/OVA/HES abrogated HES suppression of OVA-specific responses at challenge, indicating that suppression of early Alternaria-induced IL-33 release could be central to the anti-allergic effects of HES. Thus, this helminth parasite targets IL-33 production as part of its armory of suppressive effects, forestalling the development of the type 2 immune response to infection and allergic sensitization. Nature Publishing Group 2014-09 2014-02-05 /pmc/articles/PMC4016792/ /pubmed/24496315 http://dx.doi.org/10.1038/mi.2013.123 Text en Copyright © 2014 Society for Mucosal Immunology http://creativecommons.org/licenses/by-nc-nd/3.0/ This work is licensed under the Creative Commons Attribution-NonCommercial-No Derivative Works 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/. |
spellingShingle | Article McSorley, H J Blair, N F Smith, K A McKenzie, A N J Maizels, R M Blockade of IL-33 release and suppression of type 2 innate lymphoid cell responses by helminth secreted products in airway allergy |
title | Blockade of IL-33 release and suppression of type 2 innate lymphoid cell responses by helminth secreted products in airway allergy |
title_full | Blockade of IL-33 release and suppression of type 2 innate lymphoid cell responses by helminth secreted products in airway allergy |
title_fullStr | Blockade of IL-33 release and suppression of type 2 innate lymphoid cell responses by helminth secreted products in airway allergy |
title_full_unstemmed | Blockade of IL-33 release and suppression of type 2 innate lymphoid cell responses by helminth secreted products in airway allergy |
title_short | Blockade of IL-33 release and suppression of type 2 innate lymphoid cell responses by helminth secreted products in airway allergy |
title_sort | blockade of il-33 release and suppression of type 2 innate lymphoid cell responses by helminth secreted products in airway allergy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016792/ https://www.ncbi.nlm.nih.gov/pubmed/24496315 http://dx.doi.org/10.1038/mi.2013.123 |
work_keys_str_mv | AT mcsorleyhj blockadeofil33releaseandsuppressionoftype2innatelymphoidcellresponsesbyhelminthsecretedproductsinairwayallergy AT blairnf blockadeofil33releaseandsuppressionoftype2innatelymphoidcellresponsesbyhelminthsecretedproductsinairwayallergy AT smithka blockadeofil33releaseandsuppressionoftype2innatelymphoidcellresponsesbyhelminthsecretedproductsinairwayallergy AT mckenzieanj blockadeofil33releaseandsuppressionoftype2innatelymphoidcellresponsesbyhelminthsecretedproductsinairwayallergy AT maizelsrm blockadeofil33releaseandsuppressionoftype2innatelymphoidcellresponsesbyhelminthsecretedproductsinairwayallergy |